Medical Cryoablation Market

Global Medical Cryoablation Market Size, Trends & Analysis - Forecasts to 2027 By Disease Indication (Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Cardiac Arrhythmia), By End-User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Others), By Product Type (Tissue Contact Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems, Tissue Spray Probe Ablators), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on September 26 2024 with the latest and most recent market numbers

Global Medical Cryoablation Market Size

The global medical cryoablation market is projected to grow at a CAGR value of 8.4% from 2022 to 2027.

A procedure in which an extremely cold liquid or an instrument called a cryoprobe is used to freeze and destroy abnormal tissue is called as cryoablation. A cryoprobe is cooled with substances such as liquid nitrogen, liquid nitrous oxide, or compressed argon gas. Cryoablation techniques are non-intrusive, making them ideal for healing the cancerous tissues and those tissues with weakened immune systems. This technique is mostly used for the tissues of geriatric patients. As per the United Nations' World Population Prospects, the world geriatric population is predicted to almost double in 2050, from 962 million in 2017 to 2.1 billion in 2050.

According to with World Health Organization's 2018 health survey, cancer ranked as the second major cause of death worldwide, contributing to around 9.6 million deaths in 2018. Cryoablation devices aid in the diagnosis and prevention of initial stage cancer deaths and hence will be the fastest growing technology in the market. The rising prevalence of cancer and cardiovascular diseases, increased preference for minimally invasive procedures, uptime of customized probes for cryoablation, and rising physician acceptance are all contributing to the medical cryoablation market's growth.

Furthermore, various other factors such as advancements in interventional oncology, growing adoption for advanced treatment therapy for cancer in developed economies, growing prevalence of breast and lung cancer where targeted therapy is possible, rising incidence of neurological diseases are expected to drive market growth during the forecast period.

COVID-19 has posed a significant challenge to the medical and healthcare communities in recent months, pushing them to their limits. Despite the constraints of COVID-19, cryoablation market fairly did well and is expected to grow rapidly during the forecast period.

global medical cryoablation market

Global Medical Cryoablation Market: By Disease Indication

Based on the disease indication, the medical cryoablation market is segmented into cancer, prostate cancer, renal cancer, liver cancer, breast cancer, lung cancer, and cardiac arrhythmia. The breast cancer segment is expected to grow the fastest in the medical cryoablation market from 2022 to 2027. Cryoablation is a well-tolerated ambulatory therapy that has been used to treat metastatic illness and tiny breast tumors in individuals who may not be surgical candidates (1–3). Cryoablation enhances breast cancer innate immunity, improving tumor responsiveness to immunotherapy contributing to segment growth.

Global Medical Cryoablation Market: By End-User

Based on the end-user, the medical cryoablation market is segmented into hospitals & specialty clinics, ambulatory surgical centers, and others. The ambulatory surgical centre’s segment is expected to hold a larger share as compared to other segments. This dominance is large since when surgeries are performed in an ASC setting, surgeries are very often relatively short, rehabilitation seems to be significantly quicker, and the rate of infection is half that of hospitals, and expenses are often relatively low for outpatient surgery.

Global Medical Cryoablation Market: By Application

Tissue contacts probe ablators, epidermal and subcutaneous cryoablation systems, and tissue spray probe ablators are the segmentation based on product type. The tissue spray probe ablators segment is expected to grow the fastest in the medical cryoablation market from 2022 to 2027. When executing the ablation process during surgery, the unit offers significant therapeutic benefits. Furthermore, the tool aids practitioners in achieving consistent and repeatable ablation efficiency. Governments all over the globe are rising spending on healthcare, and with the rapid rate of growth in the medical field, the tissue spray probe ablators business is gaining huge popularity around the world.

asia pacific medical cryoablation market

Global Medical Cryoablation Market: By Region

As per the geographical analysis, the medical cryoablation market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico), will have a dominant share in the medical cryoablation market from 2022 to 2027. Cryoablation is predicted to become more popular soon as a result of supportive government policies, laws, and enhanced medical infrastructure, as well as increasing FDA approvals. Hence, these factors will support in boosting the market growth during the forecast period.

Moreover, the Asia-Pacific region is expected to be the fastest-growing segment in the medical cryoablation market during the forecast period. Rapidly increasing number of technologically advanced cancer therapies, increasing disposable income, effective reimbursement policies, and the development of the healthcare business are all factors that contribute to the market's growth.

Furthermore, the rising product launch strategies in emerging markets, strong manufacturing capacity, and a significant number of geriatric cancer patients in these areas have complemented market expansion.

Global Medical Cryoablation Market Share and Competitor Analysis

Medtronic Inc., Galil Medical Inc., AtriCure, Inc., IceCure Medical, CryoConcepts LP, Brymill Cryogenic Systems, CooperSurgical, Sanarus Technologies, Zimmer MedizinSystems, Boston Scientific Corporation, Impact Cryotherapy, CryoAction Limited, Cortex Technology, Stryker, Cryoalfa, Metrum Cryoflex, CryoBuilt, Inc, among others, are the key players in the medical cryoablation market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview and Validation

1.4    Data End-Users

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Medical Cryoablation Industry Overview, 2022-2027

2.1.1    Industry Overview

2.1.2    Disease Indication Overview

2.1.3    End-User Overview

2.1.4    Product Type Overview

2.1.6    Regional Overview

Chapter 3   Medical Cryoablation Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2022-2027

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1      The rising prevalence of cancer and CVDs

3.3.2    End-User Challenges

3.3.2.1    Lack of training or skilled professionals to function in cryoablation systems

3.4    Prospective Growth Scenario

3.4.1    Disease Indication Growth Scenario

3.4.2    End-User Growth Scenario

3.4.3    Product Type Growth Scenario

3.5    COVID-19 Influence over End-User Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    End-User Overview

3.11    Market Share Analysis, 2021

3.11.1    Company Positioning Overview, 2021

Chapter 4   Medical Cryoablation Market, By End-User

4.1    End-User Outlook

4.2     Hospitals & Specialty Clinics

4.2.1    Market Size, By Region, 2022-2027 (USD Billion)

4.3    Ambulatory Surgical Centers

4.3.1    Market Size, By Region, 2022-2027 (USD Billion)

4.4    Others

4.4.1    Market Size, By Region, 2022-2027 (USD Billion)

Chapter 5   Medical Cryoablation Market, By Disease Indication

5.1    End-User Outlook

5.2    Cardiac Arrhythmia

5.2.1    Market Size, By Region, 2022-2027 (USD Billion)

5.3    Prostate Cancer

5.3.1    Market Size, By Region, 2022-2027 (USD Billion)

5.4    Renal Cancer

5.4.1    Market Size, By Region, 2022-2027 (USD Billion)

5.5    Liver Cancer

5.5.1    Market Size, By Region, 2022-2027 (USD Billion)

5.6    Breast Cancer

5.9.1    Market Size, By Region, 2022-2027 (USD Billion)

5.7    Lung Cancer

5.7.1    Market Size, By Region, 2022-2027 (USD Billion)

Chapter 6   Medical Cryoablation Market, By Product Type

6.1    Tissue Contact Probe Ablators

6.1.1    Market Size, By Region, 2022-2027 (USD Billion)

6.2    Epidermal and Subcutaneous Cryoablation Systems

6.2.1    Market Size, By Region, 2022-2027 (USD Billion)

6.3   Tissue Spray Probe Ablators

6.3.1    Market Size, By Region, 2022-2027 (USD Billion)

Chapter 7   Nuclear Imaging Equipment Market, By Region

7.1    Regional outlook

7.2    North America

7.2.1    Market Size, By Country 2022-2027 (USD Billion)

7.2.2    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.2.3    Market Size, By Product Type, 2022-2027 (USD Billion)

7.2.4    Market Size, By End-User, 2022-2027 (USD Billion)

7.2.6    U.S.

7.2.6.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.2.4.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.2.4.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.2.7    Canada

7.2.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.2.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.2.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.3    Europe

7.3.1    Market Size, By Country 2022-2027 (USD Billion)

7.3.2    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.3    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.4    Market Size, By End-User, 2022-2027 (USD Billion)

7.3.6    Germany

7.3.6.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.6.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.6.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.3.7    UK

7.3.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.3.8    France

7.3.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.3.9    Italy

7.3.9.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.9.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.9.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.3.10    Spain

7.3.10.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.10.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.10.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.3.11    Russia

7.3.11.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.3.11.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.3.11.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.4    Asia Pacific

7.4.1    Market Size, By Country 2022-2027 (USD Billion)

7.4.2    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.4.3    Market Size, By Product Type, 2022-2027 (USD Billion)

7.4.4    Market Size, By End-User, 2022-2027 (USD Billion)

7.4.6    China

7.4.6.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.4.6.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.4.6.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.4.7    India

7.4.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.4.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.4.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.4.8    Japan

7.4.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.4.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.4.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.4.9    Australia

7.4.9.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.4.9.2    Market size, By Product Type, 2022-2027 (USD Billion)

7.4.9.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.4.10    South Korea

7.4.10.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.4.10.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.4.10.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.5    Latin America

7.5.1    Market Size, By Country 2022-2027 (USD Billion)

7.5.2    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.5.3    Market Size, By Product Type, 2022-2027 (USD Billion)

7.5.4   Market Size, By End-User, 2022-2027 (USD Billion)

7.5.6    Brazil

7.5.6.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.5.6.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.5.6.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.5.7    Mexico

7.5.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.5.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.5.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.5.8    Argentina

7.5.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.5.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.5.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.6    MEA

7.6.1    Market Size, By Country 2022-2027 (USD Billion)

7.6.2    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.6.3    Market Size, By Product Type, 2022-2027 (USD Billion)

7.6.4    Market Size, By End-User, 2022-2027 (USD Billion)

7.6.6    Saudi Arabia

7.6.6.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.6.6.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.6.6.3   Market Size, By End-User, 2022-2027 (USD Billion)

7.6.7    UAE

7.6.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.6.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.6.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

7.6.8    South Africa

7.6.7.1    Market Size, By Disease Indication, 2022-2027 (USD Billion)

7.6.7.2    Market Size, By Product Type, 2022-2027 (USD Billion)

7.6.7.3    Market Size, By End-User, 2022-2027 (USD Billion)

Chapter 8   Company Landscape

8.1    Competitive Analysis, 2022

8.2    Medtronic Inc

8.2.1    Company Overview

8.2.2    Financial Analysis

8.2.3    Strategic Positioning

8.2.4    Infographic Analysis

8.3    Galil Medical Inc

8.3.1    Company Overview

8.3.2    Financial Analysis

8.3.3    Strategic Positioning

8.3.4    Infographic Analysis

8.4    AtriCure, Inc

8.4.1    Company Overview

8.4.2    Financial Analysis

8.4.3    Strategic Positioning

8.4.4    Infographic Analysis

8.5    IceCure Medical

8.5.1    Company Overview

8.5.2    Financial Analysis

8.5.3    Strategic Positioning

8.5.4    Infographic Analysis

8.6    CryoConcepts LP

8.6.1    Company Overview

8.6.2    Financial Analysis

8.6.3    Strategic Positioning

8.6.4    Infographic Analysis

8.7     Brymill Cryogenic Systems

8.7.1    Company Overview

8.7.2    Financial Analysis

8.7.3    Strategic Positioning

8.7.4    Infographic Analysis

8.8    CooperSurgical

8.8.1    Company Overview

8.8.2    Financial Analysis

8.8.3    Strategic Positioning

8.8.4    Infographic Analysis

8.9     Sanarus Technologies

8.8.1    Company Overview

8.8.2    Financial Analysis

8.8.3    Strategic Positioning

8.8.4    Infographic Analysis

8.10    Zimmer MedizinSystems

8.10.1    Company Overview

8.10.2    Financial Analysis

8.10.3    Strategic Positioning

8.10.4    Infographic Analysis

8.11    Boston Scientific Corporation

8.11.1    Company Overview

8.11.2    Financial Analysis

8.11.3    Strategic Positioning

8.11.4    Infographic Analysis

8.12    Impact Cryotherapy

8.12.1    Company Overview

8.12.2    Financial Analysis

8.12.3    Strategic Positioning

8.12.4    Infographic Analysis

8.13    CryoAction Limited

8.13.1    Company Overview

8.13.2    Financial Analysis

8.13.3    Strategic Positioning

8.13.4    Infographic Analysis

8.14    Cortex Technology

8.14.1    Company Overview

8.14.2    Financial Analysis

8.14.3    Strategic Positioning

8.14.4    Infographic Analysis

8.15    Stryker

8.15.1    Company Overview

8.15.2    Financial Analysis

8.15.3    Strategic Positioning

8.15.4    Infographic Analysis

8.16    Cryoalfa

8.16.1    Company Overview

8.16.2    Financial Analysis

8.16.3    Strategic Positioning

8.16.4    Infographic Analysis

8.17     Metrum Cryoflex

8.17.1    Company Overview

8.17.2    Financial Analysis

8.17.3    Strategic Positioning

8.17.4    Infographic Analysis

8.18    CryoBuilt, Inc

8.18.1    Company Overview

8.18.2    Financial Analysis

8.18.3    Strategic Positioning

8.18.4    Infographic Analysis

8.19   Other Companies 

8.19.1    Company Overview

8.19.2    Financial Analysis

8.19.3    Strategic Positioning

8.19.4    Infographic Analysis

The Global Medical Cryoablation Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Medical Cryoablation Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global medical cryoablation market is projected to grow at a CAGR value of 8.4% from 2022 to 2027.
Medtronic Inc., Galil Medical Inc., AtriCure, Inc., IceCure Medical, CryoConcepts LP, Brymill Cryogenic Systems, CooperSurgical, Sanarus Technologies, Zimmer MedizinSystems, Boston Scientific Corporation, Impact Cryotherapy, CryoAction Limited, Cortex Technology, Stryker, Cryoalfa, Metrum Cryoflex, CryoBuilt, Inc, among others, are the key players in the medical cryoablation market.
The North American region is estimated to hold the highest market share in the medical cryoablation market.
COVID-19 has posed a significant challenge to the medical and healthcare communities in recent months, pushing them to their limits. Despite the constraints of COVID-19, cryoablation market fairly did well and is expected to grow rapidly during the forecast period.
The rising prevalence of cancer and cardiovascular diseases, increased preference for minimally invasive procedures, uptime of customized probes for cryoablation, and rising physician acceptance are all contributing to the medical cryoablation markets growth.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius